Salem Erode Investments Q1 FY27 loss widens 32% as income drops 18%

Stock price snapshot and why the update matters

Salem Erode Investments Ltd (BSE: 540181) was at ₹34 on August 25, 2026, according to the latest update provided. The counter has also seen recent volatility, with a cited close of ₹32.46, down ₹2.49 or 7.12%. Another price point in the same data set shows ₹35.4 as of August 24, 2026, and a separate intraday change of -₹1.40 or -3.95% as on August 24, 2026 at 03:50.

The latest corporate disclosures matter because they combine two key updates that investors track closely in NBFCs: quarterly financial performance and fund-raising actions. Salem Erode Investments disclosed its unaudited standalone numbers for the quarter ended June 30, 2026 (Q1 FY27). It also executed a private placement allotment of secured redeemable non-convertible debentures (NCDs) after board approvals in July.

Board meeting outcome: Q1 FY27 results approved

The company said its Board of Directors approved the unaudited standalone financial results for the quarter ended June 30, 2026. The approval took place at a board meeting held on August 13, 2026.

This disclosure was communicated as a “Board Meeting Outcome” filing. The same set of information indicates the company will publish the results in leading national and vernacular newspapers, aligning with regulatory publication requirements referenced in the update.

The board meeting calendar also reflects August 13, 2026 as the date for “Quarterly Results”. Another board-related entry shows July 23, 2026 listed under “Others”, which aligns with the NCD issuance approval described later.

Financial performance: loss widens year-on-year

For Q1 FY27, Salem Erode Investments reported a standalone net loss of ₹1.31 crore. The update states this was a 32% increase year-on-year from a net loss of ₹0.99 crore.

The same disclosure also indicates total income for the quarter came in at ₹0.91 crore, down 18% from ₹1.10 crore year-on-year. Taken together, the numbers point to a quarter where income fell while losses widened on a year-on-year basis.

A separate set of figures in the provided information expresses the loss in lakhs, stating a loss of ₹1.3097 crore for the quarter ended June 30, 2026, compared with a loss of ₹1.3877 crore in the preceding quarter. The earnings per share (EPS) for the period was reported at (₹1.14) on a basic and diluted basis.

Prior intimation: what the company told the exchange

Ahead of the August 13 board meeting, the company filed a “Board Meeting Intimation” stating the board would consider and approve the unaudited standalone financial results for Q1 FY27 ended June 30, 2026. The intimation referenced compliance under Regulation 29 and other applicable provisions of SEBI (LODR) Regulations, 2015.

The filing was digitally signed by the company secretary, Visakh T V, and carries a timestamp of August 8, 2026 at 10:25:39 IST, as captured in the provided details. The meeting was stated to be held at the company’s corporate office.

Fund-raising actions: NCD issue approved, then allotted

Alongside quarterly results, the company’s disclosures also capture a debt fund-raising activity through secured redeemable NCDs.

On July 23, 2026, the Board of Directors approved the issuance of secured redeemable NCDs aggregating ₹4.00 crore via private placement. The issuance was described as 40,000 unlisted secured NCDs of face value ₹1,000 each, issued at par, with issuance planned in one or more tranches.

Subsequently, the company allotted NCDs aggregating ₹3.69 crore on August 1, 2026. The Debenture and Bond Committee approved the allotment of 36,950 unlisted secured redeemable NCDs on a private placement basis. The information also states ICL Fincorp Limited, described as the holding company, took up ₹3.00 crore of the issue.

Debenture committee meeting: process details disclosed

The Debenture and Bond Committee meeting for the allotment took place on August 1, 2026. The meeting commenced at 02:00 PM IST and concluded at 02:30 PM IST, according to the provided disclosure.

The allotment outcome was certified by Visakh T V, Company Secretary of Salem Erode Investments. The disclosures emphasise compliance with SEBI (LODR) requirements for such actions.

Company profile mentioned in filings

The company is described in the provided content as a non-banking finance company (NBFC). Its activities include making investments, providing loans, and investing in financial instruments such as equity shares, debt instruments, and mutual funds.

That context is relevant because income and losses for NBFCs can be affected by funding costs, investment income, and lending-related performance, even though no additional drivers were quantified in the provided information.

Key facts at a glance

Market impact: what changed for investors

The immediate market context in the provided information is a weakening price trend around late August, including a reported close at ₹32.46 with a 7.12% fall. The data also reflects two nearby price points of ₹35.4 (as of August 24) and ₹34 (as of August 25), indicating notable day-to-day movement.

From an information-flow standpoint, the August 13 board approval of quarterly numbers and the August 1 NCD allotment are material events because they affect how investors assess near-term performance and funding activities. The numbers disclosed show lower total income year-on-year and a higher year-on-year loss for Q1 FY27, while the company simultaneously pursued debt funding through secured redeemable NCDs.

Analysis: why the combination of results and NCDs is important

The Q1 FY27 results highlight two measurable trends: total income fell to ₹0.91 crore from ₹1.10 crore year-on-year, and the net loss increased to ₹1.31 crore from ₹0.99 crore year-on-year. For investors, the year-on-year widening in loss alongside reduced income can raise questions around operating performance, although no additional line-item reasons were included in the provided text.

At the same time, the company has been active in private placement NCDs, approving ₹4.00 crore and allotting ₹3.69 crore. In NBFCs, such borrowings are often linked to funding requirements. The disclosures also give clarity on participation, with ₹3.00 crore taken up by the holding company, ICL Fincorp Limited, as stated.

Conclusion

Salem Erode Investments’ August 13, 2026 board meeting approved unaudited standalone results for Q1 FY27, showing total income of ₹0.91 crore and a net loss of ₹1.31 crore. Separately, the company executed an NCD allotment of ₹3.69 crore on August 1 after the board approved a ₹4.00 crore NCD issuance on July 23.

The next key updates to track, based on the provided disclosures, are the company’s ongoing regulatory publications of results and any further actions related to NCD issuances in additional tranches, if undertaken.